S. Joshi, Vilmaris Quiñones Cardona, Ogechukwu R. Menkiti
{"title":"抗利尿激素抢救治疗在新生儿持续性肺动脉高压中的应用","authors":"S. Joshi, Vilmaris Quiñones Cardona, Ogechukwu R. Menkiti","doi":"10.1542/PEDS.147.3_MEETINGABSTRACT.749","DOIUrl":null,"url":null,"abstract":"Background: Persistent pulmonary hypertension of newborn (PPHN) affects 1.9 per 1000 live births and has a varied mortality ranging between 4-33%. Although inhaled nitric oxide (iNO) has reduced the need for Extracorporeal membrane oxygenation (ECMO) in this population, refractory cases persist. Vasopressin is gaining favor as a treatment modality in neonates despite limited data and concerns for hyponatremia and decreased intestinal perfusion. Objective: To describe the effect of vasopressin on oxygenation and systemic blood …","PeriodicalId":275302,"journal":{"name":"Section on Neonatal-Perinatal Medicine Program","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Utility of Vasopressin Rescue Therapy in Neonates with Persistent Pulmonary Hypertension of the Newborn\",\"authors\":\"S. Joshi, Vilmaris Quiñones Cardona, Ogechukwu R. Menkiti\",\"doi\":\"10.1542/PEDS.147.3_MEETINGABSTRACT.749\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Persistent pulmonary hypertension of newborn (PPHN) affects 1.9 per 1000 live births and has a varied mortality ranging between 4-33%. Although inhaled nitric oxide (iNO) has reduced the need for Extracorporeal membrane oxygenation (ECMO) in this population, refractory cases persist. Vasopressin is gaining favor as a treatment modality in neonates despite limited data and concerns for hyponatremia and decreased intestinal perfusion. Objective: To describe the effect of vasopressin on oxygenation and systemic blood …\",\"PeriodicalId\":275302,\"journal\":{\"name\":\"Section on Neonatal-Perinatal Medicine Program\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section on Neonatal-Perinatal Medicine Program\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1542/PEDS.147.3_MEETINGABSTRACT.749\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section on Neonatal-Perinatal Medicine Program","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1542/PEDS.147.3_MEETINGABSTRACT.749","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Utility of Vasopressin Rescue Therapy in Neonates with Persistent Pulmonary Hypertension of the Newborn
Background: Persistent pulmonary hypertension of newborn (PPHN) affects 1.9 per 1000 live births and has a varied mortality ranging between 4-33%. Although inhaled nitric oxide (iNO) has reduced the need for Extracorporeal membrane oxygenation (ECMO) in this population, refractory cases persist. Vasopressin is gaining favor as a treatment modality in neonates despite limited data and concerns for hyponatremia and decreased intestinal perfusion. Objective: To describe the effect of vasopressin on oxygenation and systemic blood …
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
